Delirium and Agitation.

Area of Science:

• Geriatrics
• Neurology
• Critical Care Medicine

Background:

• Delirium is a common syndrome in medically compromised patients, characterized by altered consciousness and global cognitive impairment.
• It is associated with increased morbidity and mortality, posing a significant challenge in clinical settings.

Purpose of the Study:

• To outline the primary goals and comprehensive treatment strategies for managing delirium.
• To emphasize the importance of addressing underlying causes and providing supportive care.

Main Methods:

• Treatment focuses on identifying and correcting the underlying cause of delirium.
• Management includes pharmacotherapy for behavioral symptoms, supportive therapy, and environmental modifications.
• Physical restraints are considered for immediate safety until pharmacologic management is effective.

Main Results:

• Pharmacotherapy, particularly antipsychotics like haloperidol with or without lorazepam, is the treatment of choice for managing disruptive behaviors.
• Addressing environmental factors, reorientation, and sensory impairments are crucial components of care.
• Family presence and involvement can provide a calming effect and enhance patient safety.

Conclusions:

• Effective delirium management requires a multifaceted approach targeting the cause, symptoms, and environment.
• Supportive care, including family involvement and sensory management, is vital for patient recovery.
• Prompt and appropriate interventions are essential to mitigate the significant morbidity and mortality associated with delirium.